Overview

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

This study will assess the safety and tolerability of MTS while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product.

Phase:

Phase 3

Details

Lead Sponsor:

Noven Therapeutics

Collaborator:

Noven Pharmaceuticals, Inc.

Treatments:

Methylphenidate